1,2 diarylbenzimidazoles and their pharmaceutical use

Details 1,2 diarylbenzimidazoles and their pharmaceutical use 1,2 diarylbenzimidazoles and their pharmaceutical use

2008-03-18

2008-03-18

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S310700, C548S304400

Reexamination Certificate

active

07345075

ABSTRACT:
Benzimidazoles of general formula Iand the use of benzimidazole derivatives for the production of pharmaceutical agents for treatment and prophylaxis of diseases that are associated with a microglia activation are described.

REFERENCES:
patent: 5552426 (1996-09-01), Lunn et al.
patent: 0 104 727 (1984-04-01), None
patent: 0 528 164 (1993-02-01), None
patent: 0 531 883 (1993-03-01), None
patent: 0 520 200 (1993-12-01), None
patent: 0 694 535 (1996-01-01), None
patent: 1174493 (1969-12-01), None
patent: WO95/07263 (1995-03-01), None
patent: WO97/12613 (1997-04-01), None
patent: WO97/33873 (1997-09-01), None
Thomas et al., “Minocycline: Neuroprotective Mechanisms in Parkinson's Disease”, Current Pharmaceutical Design , 2004, 679-686.
Hcaplus 2005:20310 Lott et al.
Hcplus 125:300996.
Hcplus 124:289536, Burns et al.
Hcplus 122:236400.
Hcplus 132:206042.

Affiliated with

Also associated with

Rating

1,2 diarylbenzimidazoles and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,2 diarylbenzimidazoles and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2 diarylbenzimidazoles and their pharmaceutical use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2801268